Invus Public Equities, L.P. 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-04 2:46 pm Unchanged | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Invus Public Equities, L.P. | 427,141 2.500% | 0 (Unchanged) | Filing |
| 2025-10-02 5:04 pm Purchase | 2025-09-26 | 13G | TENAX THERAPEUTICS INC PAR TENX | Invus Public Equities, L.P. | 427,141 9.400% | 427,141 (New Position) | Filing |